PERK and GCN2 are eIF2α kinases known to mediate the effects of ER stress and respond to an array of diverse stress stimuli. Previously, we reported that ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation.
| INTRODUCTION
Endoplasmic reticulum (ER) is the organelle where proteins synthesized in the secretory pathway are folded and processed. Misfolded proteins are eliminated via the ER-associated degradation (ERAD) pathway to ensure that only correctly folded proteins exit the ER (Nakatsukasa & Brodsky, 2008) . When the regulatory capacity of the ERAD pathway is exhausted, misfolded proteins accumulate and trigger a stress signal that includes protein kinase PERK (PKR-like ER kinase). PERK is an ER transmembrane protein linked to diabetes and cancer progression (Bobrovnikova-Marjon et al., 2010; Zhang et al., 2006) . ER stress increases the transcriptional level of PERK as well as its kinase activity via auto-phosphorylation (Zhang et al., 2015) . As a result, PERK gain-of-function leads to phosphorylation of eIF2α (eukaryotic translation initiation factor 2α) and Nrf2, a transcription factor, to reduce general protein synthesis and increase the expression of components involved in protein folding (Cullinan & Diehl, 2006; Cullinan et al., 2003) .
Apart from PERK, GCN2 (or EIF2AK4) has also been shown to control eIF2α phosphorylation in response to ER stress (Baird & Wek, 2012; Hamanaka, Bennett, Cullinan, & Diehl, 2005) . GCN2 is primarily activated by nutritional deprivation and it is also known to be activated in response to UV irradiation, hypoxia, and viral infection. Although studies have strongly suggested that additional GCN2 substrates remain to be discovered (Grallert & Boye, 2007) , eIF2α is the only characterized substrate of GCN2 so far. Both GCN2 and PERK have been implicated to cooperate in regulating stress signaling in tumors (Donnelly, Gorman, Gupta, & Samali, 2013) . In light of this, the possibility that GCN2 and PERK share additional downstream targets would seem likely but has not been addressed. The forkhead box O (FOXO) transcription factors are critical players that modulate the expression of genes involved in growth, stress resistance, neurological diseases, cancer, and metabolism (Coomans de Brachene & Demoulin, 2016; Fluteau et al., 2015; Murtaza et al., 2017) . Drosophila possesses one FOXO factor, whereas human has FOXO1,3,4, and 6, among which FOXO1 and FOXO3 are the main isoforms (Webb & Brunet, 2014) . All FOXO proteins are signaling integrators regulated by multiple pathways. For example, regulation of FOXO by AKT kinase is a key output of insulin signaling and conserved through evolution (Zhang, Thompson, Hietakangas, & Cohen, 2011) . Insulin signaling via PI3K leads to elevated AKT activity. AKT-mediated phosphorylation of FOXO proteins promotes their retention in the cytoplasm, thereby suppressing the transcription of FOXO targets.
Previously, we reported that ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation (Zhang et al., 2013) . PERK acts directly on FOXO to override AKT-induced suppression of FOXO activity. However, the contribution of FOXO activity to PERK function was not explored. Here, we provide evidence that FOXO activity in turn is important to PERK function in vivo. Furthermore, we demonstrate that GCN2 is able to regulate FOXO activity in an evolutionarily conserved manner similar to PERK. Our results also suggest that mediation of FOXO by both GCN2 and PERK is functionally redundant.
| RESULTS

| FOXO is required for PERK function in vivo
Although PERK was proved to phosphorylate FOXO and facilitate its activity (Zhang et al., 2013) , whether FOXO activity was required for PERK function remains obscure. To address this, we first assessed the in vivo impact of PERK in Drosophila. Over-expressing FOXO in the Drosophila eye is known to cause small rough eye phenotype (Hietakangas & Cohen, 2007; Junger et al., 2003) . Consistent with the regulation of PERK on FOXO, over-expression of PERK enhanced the FOXO phenotype (Figure 1a ), but on its own, did not significantly reduce eye size (Figure 1b , quantified in Figure 1c ; expression of the PERK transgene was verified in Supporting Information Figure S1A ). Hence, the Drosophila eye provides a sensitized system for testing PERK function.
Hrd3 is a component of the ERAD complex (Carvalho, Goder, & Rapoport, 2006; Smith, Ploegh, & Weissman, 2011) . Down-regulation of Hrd3 by RNAi has been shown to induce ER stress and further reduce the area of eye overexpressing FOXO (Zhang et al., 2013) . On its own, Hrd3 depletion had no effect on eye size (Figure 1b,c ; efficacy of the RNAi transgene was verified by PCR in Supporting Information Figure S1B ). However, depleting Hrd3, together with over-expressing PERK, was observed to cause smaller eyes (Figure 1b,c) . Combined with the FOXO/ PERK interaction mentioned above, these results suggest that the small eye phenotype is an effect relevant to PERK function.
The lack of an obvious eye size phenotype resulting from PERK over-expression alone presumably reflects the magnitude of PERK up-regulation generated with the GMR-GAL4 driver during the phase of eye imaginal disk growth. To enhance the PERK level driven by GAL4 (Busson & Pret, 2007) , PERK over-expressing flies were raised at 29°C, which then produced an obvious small eye phenotype (Figure 1d ,e). To further test the in vivo contribution of FOXO activity to PERK function, we monitored the eye size of these flies by lowering FOXO activity. Removing one copy of the FOXO gene in combination with FOXO RNAi produced a nearly normal-sized eye, significantly restoring the size phenotype caused by PERK over-expression (Figure 1d ,e; efficacy of FOXO RNAi transgene at 29°C was verified by PCR in Supporting Information Figure  S1C ). This result clearly suggests FOXO is a downstream effector of PERK in vivo.
| GCN2 promotes FOXO activity in Drosophila
GCN2 is a protein kinase related to PERK. GCN2 and PERK have both been shown to mediate the effects of ER stress by phosphorylation of eIF2α in human cells (Hamanaka et al., 2005) . However, unlike PERK, depletion of Drosophila GCN2 did not influence the effects of FOXO over-expression in the eye (Figure 2a , quantified in Figure 2b ). Given that GCN2 is primarily a sensor of nutritional deprivation and ER stress, we speculated that GCN2 kinase was inactive in the eye under our food conditions. Then if GCN2 was able to regulate FOXO, we would expect this regulation occurred only in the stressed eye. This proved to be the case, as depleting GCN2 together with Hrd3 counteracted the effects of FOXO over-expression, leading to an increase in eye size (Figure 2a, b) .
To ask whether this regulation also occurred in other tissues, we expressed GCN2 RNAi ubiquitously under tubulin-GAL4 and detected a strong suppression of the mRNA level of 4E-BP (eIF4E binding protein) (Figure 2c ), a wellestablished transcriptional target of FOXO in Drosophila (Junger et al., 2003) . These findings suggest that GCN2 also regulates FOXO activity in vivo.
|
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| Conservation of GCN2/FOXO regulation in human cells
FOXO1 and FOXO3 are two human FOXO isoforms that are ubiquitously expressed (Coomans de Brachene & Demoulin, 2016) . To investigate whether GCN2 also regulates FOXO in human cells, we made use of a luciferase reporter containing the human IRS-2 promoter as readout of FOXO1 activity (Puig & Tjian, 2005) . Expression of FOXO1 in human H1299 cells increased the reporter expression. Expression of human GCN2 alone had little effect, but GCN2 potentiated the effect of FOXO1 (Figure 3a) . Expression of FOXO1 and GCN2 were verified by PCR (Supporting Information Figure  S2A ,B).
Synergistic enhancement of reporter activity was also observed when cells were transfected to express GCN2 and FOXO3 with a luciferase reporter containing four synthetic FOXO3 recognition sites (4FRE) (Teleman, Hietakangas, Sayadian, & Cohen, 2008) (Figure 3b ). Human glutamine synthetase (GS) is a direct downstream effector of FOXO3 To combine all datasets, average size of GMR eyes from each experiment was used to normalize the dataset of that batch. Tukey's HSD test: (***) p < 0.001; (N.S.) p > 0.05, indicates that there was no significant effect of bringing down Hrd3 or over-expressing PERK alone. (d) Adult eyes expressing GMR-GAL4 and UAS-PERK and/or a UAS-FOXO RNAi transgene with one mutant copy of FOXO gene. Loss-of-function alleles FOXO 21 and FOXO 25 were used to remove one copy of FOXO. Experiments were performed at 29°C to enhance the effects of PERK gain-offunction. (e) Plot of total eye area measured in pixels from digital images using ImageJ. Error bars indicate standard deviation from normalized measurement of at least 18 eyes from three independent experiments for each genotype. Average size of GMR from each experiment was used to normalize the dataset of that batch. Tukey's HSD test: (***) p < 0.001. (N.S.) indicates that there was no significant effect of bringing down FOXO activity on eyes only expressing GMR-GAL4. To compare two groups, two-tailed t test was used. For comparison of more than two groups, one-way analysis of variance (ANOVA) tests were used for all datasets, followed by a Tukey's multiple-comparison test. Details about ANOVA are shown in Supporting Information Table S1
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involved in mTOR-modulated autophagy and neurodegenerative diseases (Bos et al., 2006; van der Vos et al., 2012) .
To further verify the regulation of GCN2 on FOXO3, a luciferase reporter containing endogenous GS promoter was used as readout of FOXO3 activity (van der Vos et al., 2012) . Comparable results were also obtained when cells were transfected to express this GS reporter (Supporting Information Figure S2C ). Expression level of FOXO3 was assessed by PCR (Supporting Information Figure S2D ).
| Regulation of FOXO activity by both
GCN2 and PERK
As mentioned above, our data demonstrated that both GCN2 and PERK are able to regulate FOXO activity. PERK is known to mediate FOXO1 phosphorylation at site S298. An S298A mutation was shown to reduce the responsiveness of FOXO1 to PERK (Zhang et al., 2013) . To assess the role of site S298 in mediating the effect of GCN2 on FOXO1, two forms of FOXO1 were co-expressed with GCN2 in cells (Figure 3c ). In a similar manner, the S298A mutant FOXO1 also failed to respond to the potentiating effect of GCN2, indicating that GCN2 regulates FOXO through the same mechanism as PERK. Next, we asked whether GCN2 and PERK function redundantly to regulate FOXO. To address this, endogenous GCN2 was depleted by siRNA treatment, and no strong influence was observed on FOXO3 reporter expression without FOXO3 over-expression (Supporting Information Figure  S3A ). Efficacy of GCN2 siRNA treatment was assessed by PCR (Supporting Information Figure S3B ). However, when ectopic FOXO3 was expressed, GCN2 depletion lowered FOXO3's ability to induce the reporter expression (Figure 3d ), suggesting the loss of endogenous GCN2 to potentiate FOXO3 activity. In contrast, the reporter activity directed by FOXO3 was refractory to GCN2 depletion when cells were simultaneously transfected to express PERK (Figure 3d ; expression level of PERK was assessed in Supporting Information Figure S3C ). The insensitivity of FOXO3's activity to GCN2 RNAi in the presence of PERK indicates that PERK is able to compensate for the absence of GCN2 on the regulation of FOXO.
| DISCUSSION
The eIF2α kinase GCN2 is known to regulate lipid metabolism, DNA repair, and survival in response to a subtype of environmental stresses including starvation, UV irradiation, and viral infection. It was initially described that these functions were not fully dependent on the phosphorylation of eIF2α, the only characterized substrate of GCN2 so far (Donnelly et al., 2013) . Whether GCN2 targets additional downstream substrates has not been addressed. The work reported here provides evidence for a model through which GCN2 modulates FOXO activity in an evolutionarily conserved manner.
F I G U R E 2 GCN2 is involved in the regulation of FOXO. (a) Adult eyes expressing GMR-GAL4 and UAS-Hrd3 RNAi, UAS-FOXO w/wo
UAS-RNAi to deplete GCN2. (b) Quantification of the total area of affected eyes of the indicated genotypes. Error bars indicate standard deviation from normalized measurement of at least 18 eyes from three independent experiments for each genotype. To combine all datasets, average size of GMR>Hrd3 RNAi from each experiment was used to normalize the dataset of that batch. Tukey's HSD test: (***) p < 0.001; (N.S.) indicates that there was no significant effect of bringing down GCN2 activity on eyes over-expressing FOXO. Details of statistical analysis by ANOVA are shown in Supporting Information Table S1 . (c) Normalized mRNA levels of 4E-BP and GCN2 by quantitative RT-PCR. Adult male flies expressed GCN2 RNAi ubiquitously under tubulin-GAL4 (Tub-Gal4) control (gray bars). Controls expressed tubulin-GAL4 without the UAS-RNAi transgene (white bars). Total RNA was extracted and normalized for cDNA synthesis before Q-PCR. RNA levels were normalized to Kinesin mRNA. Error bars represent standard deviation from three independent experiments. Student's t test: (**) p < 0.01; (***) p < 0.001 | Genes to Cells YOU et al.
FOXO transcription factors are an important family of proteins known to coordinate growth and survival factors with various stress events. Our finding raises the possibility that FOXO uses GCN2 as a sensor to activate stress responses. This allows GCN2 to translate stress signals into the dynamic gene expression programs controlled by FOXO, providing a means for GCN2 to influence many other physiological and pathological processes independent of eIF2α. Understanding these mechanisms thus may reveal potential targets for new therapeutics to treat diseases caused by those environmental stimuli.
ER stress is associated with cell apoptosis, neurological diseases, obesity, and cancer (Malhi & Gores, 2008) . Earlier, we have shown that regulatory interplay between ER stress and the insulin pathway operates at the level of PERK to enhance FOXO activity and lead to insulin resistance (Zhang et al., 2013) . Here, we further show that PERK and GCN2 are likely to redundantly regulate FOXO activity through a similar mechanism. Why is FOXO regulated by both eIF2α kinases PERK and GCN2? In the scenario of ER stress, it appears that PERK and GCN2 are activated by the same input and elicit the same outcome, thus constituting a feed-forward motif. In multicellular organisms, feed-forward motifs are often used to make cell fate decisions robust to environmental noise (Li, Cassidy, Reinke, Fischboeck, & Carthew, 2009 ). The FOXO transcription factors are master signaling integrators being regulated at multiple levels. We speculate that cooperation of the two kinases allows for a rapid onset of FOXO responses to ER stress while mitigating the effects of noise from other signaling. In addition, as illustrated by our in vivo data, regulation of FOXO by GCN2 is more likely to occur in some tissues but not in the eye under normal conditions. This is different from PERK as inhibition of PERK alone is sufficient to offset the effects of FOXO over-expression in the eye (Zhang et al., 2013 ). These observations may reflect different basal activities of eIF2α kinases in tissues receiving diverse stress stimuli. Given that PERK and GCN2 primarily respond to distinct types of stresses, similar regulation via the two kinases perhaps is functionally redundant but not physiologically redundant.
F I G U R E 3
Human PERK and GCN2 regulate FOXO activity. (a) Luciferase reporter assays for human FOXO1 activity. H1299 cells were transfected to express a FOXO1 responsive luciferase reporter derived from the IRS-2 gene. Cells were cotransfected to express human FOXO1 and GCN2 as indicated. Error bars represent standard deviation from three independent experiments. (b) Luciferase reporter assays for human FOXO3 activity. H1299 cells were transfected to express a luciferase reporter containing four synthetic FOXO3 recognition sites. Cells were cotransfected to express human FOXO3 and GCN2 as indicated. Data represent the average of three independent experiments. (c) FOXO1 luciferase reporter assays as in A, except cells were cotransfected to express intact human FOXO1 or a S298A mutant FOXO1 w/wo GCN2 as indicated. Data represent the average of three independent experiments. (d) FOXO3 luciferase reporter assays as in B, except cells were cotransfected to express FOXO3 and PERK w/wo GCN2 siRNA treatment as indicated. Error bars represent standard deviation from four independent experiments. One-way ANOVA tests were used for all datasets, followed by a Tukey's multiple-comparison test. Tukey's HSD test: (**) p < 0.01; (***) p < 0.001; (N.S.) p > 0.05. For details, see Supporting Information Table S1 Protein synthesis is one of the most energy-consuming processes, taking more than 50% cellular energy and modulating the investment of resources (Tohyama, Yamaguchi, & Yamashita, 2008) . In eukaryotic cells, the initiation of protein translation strictly relies on eIF2α. Phosphorylation of eIF2α attenuates general protein synthesis but paradoxically promotes the translation of certain mRNA including transcription factor ATF4. Previously, PERK has been revealed to inhibit protein synthesis while activating Nrf2 to selectively promote gene expression to defy stressors (Cullinan et al., 2003) . Our findings propose a similar scenario in which GCN2 down-regulates translation via eIF2α, while upregulating transcription via FOXO. All these efforts modify both translational and transcriptional programs, reflecting a redirection of energy as well as a redistribution of resources inside cells upon stress stimuli. Furthermore, the integration of eIF2α with FOXO by PERK and GCN2 may also indicate a time-dependent impact from stresses on cell fate, as transcriptional control is usually considered to be slower and less labile compared to the transient phosphorylation modifications of proteins (Zhang et al., 2011) . Given the involvement of downstream growth and apoptosis pathways, cells might use short-term and long-term mechanisms, respectively, to cope with acute and chronic stresses, balancing between survival and apoptosis (Vandewynckel et al., 2013) .
A recent study in Drosophila by Kang and coworkers showed that GCN2 was required for 4E-BP induction under conditions of dietary restriction (Kang et al., 2017) . This is consistent with our observation although their point was mostly related to the amino acid deprivation response. 4E-BP is widely known to be controlled under stress conditions by FOXO at the level of transcription and by TOR signaling at the post-translational level (Hietakangas & Cohen, 2009; Teleman, Chen, & Cohen, 2005) . In mouse and human, GCN2 has been shown to function as an upstream inhibitor of mTOR through an unknown mechanism (Xiao et al., 2011) . FOXO3-induced GS expression has also been reported to inhibit mTOR and consequently activate autophagy (van der Vos et al., 2012) . Here, our data show that GCN2 facilitates GS expression in a FOXO3 dependent manner (Supporting Information Figure S2C ). Whether GCN2 attenuates mTOR activity via FOXO3/GS will be an intriguing question for future study.
| EXPERIMENTAL PROCEDURES
| Fly genetics
Unless otherwise indicated, all stocks and crosses were maintained at 25°C on a medium containing agar 0.8% (w/v), cornmeal 5.82% (w/v), dextrose 5.09% (w/v), Brewer's dry yeast 2.36% (w/v), and 10% Nipagin 3% (v/v). GMR-Gal4 was described by (Hietakangas & Cohen, 2007) . Tub-Gal4 was described by (Lee & Luo, 1999) . UAS-FOXO, UASRNAi-Hrd3, and UAS-PERK were described by (Zhang et al., 2013) . FOXO 21 and FOXO 25 were described by (Junger et al., 2003) . UAS-RNAi-FOXO (stock number 27656) line was obtained from the Bloomington Stock Center. UASRNAi-GCN2 (ID32664) was from Vienna Drosophila Resource Center.
| Quantitative RT-PCR
Total RNA was extracted using QIAGEN RNeasy Mini Kit and treated with On-Column DNase (QIAGEN RNase-free DNase) to eliminate genomic DNA contamination. Reverse transcription to synthesize the first strand used oligo-dT primers and Superscript RT-III (Invitrogen). PCR was performed and analyzed on Applied Biosystems 7500 fast realtime PCR system. The following primers were used for Drosophila transcripts: Kinesin-f, 5′-GCTGGACTTCGGTCGTAGAG-3′; Kinesin-r, 5′-CTTTTCATAGCGTCGCTTCC-3′; rp49-f, 5′-GCTAAG CTGTCGCACAAA-3′; rp49-r, 5′-TCCGGTGGGCAGCATG TG-3′; GAPDH-f, 5′-GAGCAAGGACTAAACTAGCCAA A-3′; GAPDH-r, 5′-CAACAGTGATTCCCGACCA-3′; PE RK-f, 5′-AACATCGTGCGATACTTCCATTCC-3′; PERK-r, 5′-TCCTCTTCTTCCTGCCAACCAG-3′; Hrd3-f, 5′-GCC TGTGGAACGAAAGTCTGATC-3′; Hrd3-r, 5′-ACACTTCA GTGGATTTGCGTTTG-3′; FOXO-f, 5′-CTCATCCAATG CCAGTTCCT-3′; FOXO-r, 5′-CTGCGTCATCGTTGTG TTCT-3′; 4E-BP-f, 5′-GAAGGGAGTACGCGGAGTTC-3′; 4E-BP-r, 5′-CACCACTCCTGGAGGCACCAA-3′; GCN2-f, 5′-GGATGAAGAGGACAGCTCATCCAG-3′; GCN2-r, 5′-TCAGAGTCCTCCATGTTGGGTATG-3′. Kinesin, rp49, and GAPDH were used as house-keeping genes for normalization. Data were adopted when comparable results were obtained after normalization, at least, to two house-keeping genes.
The following primers were used for human transcripts: Actin-f, 5′-GATGCGTAGCATTTGCTGCATGG-3′; Actin-r, 5′-TGAGGCTAGCATGAGGTGTGTG-3′; KIF-f, 5′-GCTCAACAGATGGCGTAATGGG-3′; KIF-r, 5′-GAA AGCTTCCAAGTTGGCTTTCTC-3′; Rp132-f, 5′-ATCTC CTTCTCGCTGGCGATTG-3′; Rp132-r, 5′-AGGTGAGGA AGAATCCTGGAAGG-3′; FOXO1-f, 5′-GGAGTTTAGCC AGTCCAACTCG-3′; FOXO1-r, 5′-GCTCAGGTTGCTCA TGAAGTCG-3′; FOXO3-f, 5′-CTGTCACCTTCAGTAA GCAAGCC-3′; FOXO3-r, 5′-AGATTCATGGTGCCTGCCA TATC-3′; GCN2-f, 5′-GTGGTTCCCATTGTGAGTGTG C-3′; GCN2-r, 5′-GGTCTGAAGTCGAGTTTGTACCTG-3′; PERK-f, 5′-TACAGCTGGCCTCTATACATTCCC-3′; PERK-r, 5′-AAGACATTGTAGAAGCTGCCAGAG-3′. Actin, KIF, and Rp132 were used as house-keeping genes for normalization. Data were adopted when comparable results were | Genes to Cells YOU et al.
obtained after normalization, at least, to two house-keeping genes.
| Cell culture and treatments
Human H1299 and Hela cells were cultured with high glucose DMEM media supplemented with 10% FBS at 37°C and 5% CO 2 . Cells were transfected using FuGENE 6 or Lipofectamine 3000. pEGFP-N1 from Invitrogen was used to express GFP as control. GCN2 siRNA (QIAGEN SI03058629) or a negative control siRNA (QIAGEN SI03650325) was transfected using HiPerFect reagent.
Firefly and Renilla were measured using DualLuciferase Reporter Assay System (Promega) on Tecan 200Pro or Spark instrument. pGL-Basic-Renilla (described in Teleman et al., 2008) was transfected to express Renilla as transfection control for normalization. pcDNA-FOXO1 and pGL-IRS-Firefly were described in (Puig & Tjian, 2005) . pcDNA-FOXO3 was described in (Mattila, Kallijarvi, & Puig, 2008) . pCMV-PERK was from OriGene and described in (Zhang et al., 2015) . pGL-4FRE-Firefly was described in (Teleman et al., 2008) . pcDNA-DEST40-GCN2 was cloned from pENTR223-GCN2 (HsCD00080314 from the PlasmID Repository of the DNA Resource Core at Harvard Medical School) through Gateway system. The reporter construct directed by -2520/+105 bp from the human glutamine synthetase (GS) gene region was a gift from Frank Gaunitz (Gaunitz, Weber, Scheja, & Gebhardt, 2001 ).
| Statistical analysis
Two-tailed student's t test was used to compare two groups. For comparison of more than two groups, one-way analysis of variance (ANOVA) test was used, with a Tukey's honest significant difference (HSD) test to determine whether each comparison was statistically significant. ANOVA was carried out using IBM SPSS Statistics 20 software. Detailed information about ANOVA is listed in Supporting Information Table S1 .
